Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Definium Therapeutics, Inc. DFTX

Set alert

Price alert · DFTX

All alert types
34.23 USD +1.76 +5.42%

As of Nov 3, 10:05 AM ET

Bid
34.14 × 1
Ask
34.29 × 1
32.73 Day range 34.62
10.47 52-week range 49.70
YTD
+155.64%
1 year
+178.52%
Open
32.99
Prev close
32.47
Mkt cap
4.61B
Vol
159.69K
Avg vol
2.18M
EPS
-3.43
P/E
0.00
Div yield
0.00%
More statistics
Low
32.73
High
34.62
Forward P/E
-16.73
Beta
2.21
Short ratio
4.32
Inst. own
96.39%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
37.77
200-d avg
29.60
1y target
72.56

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 6, 2025Earnings: -0.78; estimate -0.52; surprise -50%
  • May 7, 2026Earnings: -0.71; estimate -0.47; surprise -51.06%
  • Aug 6, 2026Earnings: -1.44; estimate -0.54102; surprise -166.16%
Signals (25)
NameDateAgo
RSI: OverboughtMar 1, 20268 months ago
SMA: BullishJul 1, 20251 year ago
SMA: BearishJun 1, 20251 year ago
SMA: BullishMay 1, 20251 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BullishNov 1, 20242 years ago
SMA: BullishOct 1, 20242 years ago
SMA: BearishAug 1, 20242 years ago
SMA: BearishAug 1, 20242 years ago
SMA: BullishMar 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BearishSep 1, 20233 years ago
MACD: Buy SignalSep 1, 20233 years ago
SMA: BullishJun 1, 20233 years ago
SMA: BearishDec 1, 20214 years ago
MACD: Sell SignalOct 1, 20215 years ago
SMA: BearishAug 1, 20215 years ago
RSI: OverboughtOct 1, 20206 years ago
SMA: BullishMar 1, 20206 years ago
RSI: OverboughtMar 1, 20206 years ago

Newest 20 of 25.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 72.56 +112.0% upside
Target (low)
55.00
Target (mean)
72.56
Target (high)
91.00
Ratings (0m) 19 19 buy · 0 hold · 0 sell
  • Strong buy5
  • Buy14
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 19
  • 1 month ago 18
  • 2 months ago 18

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DFTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.56065-0.70 – -0.45-0.78+28.1%00.0%14
Next quarter-0.53494-0.74 – -0.42-0.50-7.0%00.0%14
Current year-3.19-3.59 – -2.93-2.06-54.7%00.0%15
Next year-1.94-4.16 – 0.05-3.19+39.1%29.32M0.0%14

Upgrades and downgrades

The latest rating changes

DFTX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026JP MorganInitiated—Overweight
Sep 15, 2026Canaccord GenuityMaintainedBuyBuy
Sep 15, 2026BairdMaintainedOutperformOutperform
Sep 14, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 14, 2026NeedhamReiteratedBuyBuy
Sep 11, 2026RBC CapitalReiteratedOutperformOutperform
Aug 18, 2026B of A SecuritiesInitiated—Buy
Aug 14, 2026Maxim GroupMaintainedBuyBuy
Aug 13, 2026Jones TradingMaintainedBuyBuy
Aug 13, 2026Canaccord GenuityMaintainedBuyBuy
Aug 13, 2026RBC CapitalMaintainedOutperformOutperform
Aug 13, 2026Wells FargoMaintainedOverweightOverweight
Aug 13, 2026BairdMaintainedOutperformOutperform
Aug 12, 2026NeedhamMaintainedBuyBuy
Aug 7, 2026Piper SandlerReiteratedOverweightOverweight
Jul 27, 2026Wells FargoInitiated—Overweight
Jul 24, 2026Piper SandlerReiteratedOverweightOverweight
Jul 8, 2026StifelMaintainedBuyBuy
Jun 30, 2026Canaccord GenuityMaintainedBuyBuy
Jun 24, 2026Jones TradingMaintainedBuyBuy
Jun 23, 2026BairdMaintainedOutperformOutperform
Jun 23, 2026NeedhamMaintainedBuyBuy
Jun 22, 2026Leerink PartnersMaintainedOutperformOutperform
Jun 22, 2026OppenheimerMaintainedOutperformOutperform
Jun 16, 2026Canaccord GenuityMaintainedBuyBuy
May 8, 2026Piper SandlerMaintainedOverweightOverweight
Apr 22, 2026Leerink PartnersMaintainedOutperformOutperform
Apr 17, 2026StifelInitiated—Buy
Apr 16, 2026Canaccord GenuityMaintainedBuyBuy
Apr 10, 2026Piper SandlerInitiated—Overweight